SF3B1 and myelodysplastic syndrome: Mutated variants of SF3B1 (SF3B1MUT) are seen in hematological malignancies like CLL and myelodysplastic syndromes (MDS) but also in solid tumors such as uveal melanoma (UM), mucosal melanoma, BRCA, pancreatic, and prostate cancer [105,106].